Influence of daptomycin doses on the outcomes of VRE bloodstream infection treated with high-dose daptomycin
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Influence of daptomycin doses on the outcomes of VRE bloodstream infection treated with high-dose daptomycin
Authors
Keywords
-
Journal
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2022-05-11
DOI
10.1093/jac/dkac164
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Daptomycin in the treatment of enterococcal bloodstream infections and endocarditis: a EUCAST position paper
- (2020) J. Turnidge et al. CLINICAL MICROBIOLOGY AND INFECTION
- Pharmacodynamics of daptomycin when prescribed in combination with other antibiotics for treatment of enterococcal bacteremia
- (2019) Lindsay M. Avery et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Efficacy and safety of daptomycin versus linezolid treatment in patients with vancomycin-resistant enterococcal bacteraemia: an updated systematic review and meta-analysis
- (2019) Changcheng Shi et al. Journal of Global Antimicrobial Resistance
- Variability of daptomycin minimum inhibitory concentrations for Enterococcus faecium when measured by reference broth microdilution and gradient diffusion tests
- (2018) Shelley A. Campeau et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Effect of Statin Coadministration on the Risk of Daptomycin-Associated Myopathy
- (2018) Ryan K Dare et al. CLINICAL INFECTIOUS DISEASES
- A retrospective clinical comparison of daptomycin vs daptomycin and a beta-lactam antibiotic for treating vancomycin-resistant Enterococcus faecium bloodstream infections
- (2018) Yu-Chung Chuang et al. Scientific Reports
- Pharmacodynamic Analysis of Daptomycin-Treated Enterococcal Bacteremia: It Is Time to Change the Breakpoint
- (2018) Lindsay M Avery et al. CLINICAL INFECTIOUS DISEASES
- Influence of Minimum Inhibitory Concentration in Clinical Outcomes ofEnterococcus faeciumBacteremia Treated With Daptomycin: Is it Time to Change the Breakpoint?
- (2016) Bhavarth S. Shukla et al. CLINICAL INFECTIOUS DISEASES
- Daptomycin versus linezolid for the treatment of vancomycin-resistant enterococcal bacteraemia: implications of daptomycin dose
- (2016) Y.-C. Chuang et al. CLINICAL MICROBIOLOGY AND INFECTION
- Comparison of the Effectiveness and Safety of Linezolid and Daptomycin in Vancomycin-Resistant Enterococcal Bloodstream Infection: A National Cohort Study of Veterans Affairs Patients
- (2015) Nicholas S. Britt et al. CLINICAL INFECTIOUS DISEASES
- -Lactam combinations with daptomycin provide synergy against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium
- (2015) J. R. Smith et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bacteremia: systematic review and meta-analysis
- (2014) Yu-Chung Chuang et al. BMC INFECTIOUS DISEASES
- Ceftobiprole and ampicillin increase daptomycin susceptibility of daptomycin-susceptible and -resistant VRE
- (2014) B. J. Werth et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Evaluation of the novel combination of daptomycin plus ceftriaxone against vancomycin-resistant enterococci in an in vitro pharmacokinetic/pharmacodynamic simulated endocardial vegetation model
- (2014) A. Hall Snyder et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Systematic Review and Meta-Analysis of Linezolid versus Daptomycin for Treatment of Vancomycin-Resistant Enterococcal Bacteremia
- (2013) Eleni P. Balli et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ceftaroline Restores Daptomycin Activity against Daptomycin-Nonsusceptible Vancomycin-Resistant Enterococcus faecium
- (2013) George Sakoulas et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Current Perspective on Daptomycin for the Clinical Microbiologist
- (2013) R. M. Humphries et al. CLINICAL MICROBIOLOGY REVIEWS
- Correlation between Mutations inliaFSRof Enterococcus faecium and MIC of Daptomycin: Revisiting Daptomycin Breakpoints
- (2012) Jose M. Munita et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ampicillin Enhances Daptomycin- and Cationic Host Defense Peptide-Mediated Killing of Ampicillin- and Vancomycin-Resistant Enterococcus faecium
- (2011) George Sakoulas et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Management of multidrug-resistant enterococcal infections
- (2011) C.A. Arias et al. CLINICAL MICROBIOLOGY AND INFECTION
- Daptomycin Exposure and the Probability of Elevations in the Creatine Phosphokinase Level: Data from a Randomized Trial of Patients with Bacteremia and Endocarditis
- (2010) Sujata M. Bhavnani et al. CLINICAL INFECTIOUS DISEASES
- Influence of Genospecies of Acinetobacter baumannii Complex on Clinical Outcomes of Patients with Acinetobacter Bacteremia
- (2010) Y.-C. Chuang et al. CLINICAL INFECTIOUS DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now